Established in 2011, SnackSafely.com provides straightforward, actionable information to help improve the lives of the estimated 32 million people in the US suffering with food allergies.

We strive to eliminate anaphylaxis by leveraging our on-line properties to educate, advocate, and connect the allergic community with products and services that help toward achieving this goal.

Our blog covers topics of interest to the food allergy community including news reports; ongoing research, clinical studies, trials and progress toward treatment and cure; general advocacy; and advice regarding food safety and school policies.

Please see our Terms of Service and Privacy Policy.

Tag: Food and Drug Administration (FDA)

The FDA Has Relaxed Labeling Requirements Under COVID-19. What it Means...

Pending Litigation Shows Food Allergy Treatments in Development are Sometimes Overhyped

Sporadic Shortages of Epinephrine Devices Continue

FDA Warns of Possible Malfunctions for EpiPen, EpiPen Jr, and Mylan’s...

FDA Has Questions About Viaskin Peanut Efficacy, Delays Meeting with DBV...

Aimmune Provides FDA Mandated Program for Patients Considering Treatment of Peanut...

FDA Advisory Committee Meeting to Review Viaskin Peanut for the Treatment...

FDA Opens Door for Clinical Development of Aquestive Therapeutics Anaphylaxis Treatment

What You Need to Know About the First Peanut Allergy Treatment...

FDA Approves Aimmune’s PALFORZIA as First Treatment for Peanut Allergy

Your School On Our Map

Put Your School on the Map